 |
|
|
| |
Efficacy of once-weekly MK-8591 in SIV infected rhesus macaques
|
| |
| |
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy
June 8-10, 2016, Washington, DC, USA
Jay A. Grobler, Deborah Nicoll-Griffith, Ming-Tain Lai, Kerry Fillgrove, Andreas Lindauer, Matthew L. Rizk, Daria J. Hazuda
Merck & Co., Inc. West Point, PA, USA
CROI/2016:
A Single Monotherapy Dose of MK-8591,a Novel NRTI, Suppresses HIV for Ten Days - (02/24/16)
Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis - (02/24/16)
|
| |
|
|
|
|
|
